EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Therapeutic Potentials of the Seaweed-Derived Compounds for Alzheimer’s Disease

Keanie Ward, Michael H Cole iD, Lyn R Griffiths iD, Heidi G Sutherland iD, Pia Winberg iD, Barbara J Meyer iD, Francesca Fernandez iD

Molecules · 19.11.2025 · 30 (22) · 4456

DOI: 10.3390/molecules30224456 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecules, online erschienen am 19.11.2025. Verfasst von Keanie Ward und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Behavioural and Health Sciences, Faculty of Health Sciences, Australian Catholic University, Banyo, QLD 4014, Australia. Hauptthemen laut MEDLINE: Seaweed, Alzheimer Disease, Neuroprotective Agents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 220 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cognitive decline associated with healthy ageing and pathological conditions is driven by multifactorial processes, including oxidative stress, mitochondrial dysfunction and chronic neuroinflammation. Alzheimer’s Disease (AD), a progressive neurodegenerative disorder affecting cognition and behaviour, is the leading cause of dementia worldwide. Current pharmacological interventions provide modest and transient benefits, targeting limited molecular pathways with safety and cost concerns, underscoring the need for safe, accessible and multi-targeted strategies. This review explores new avenues of therapy with a focus on bioactive compounds derived from brown, red and green seaweeds and their potential to modulate key mechanisms underlying AD. Preclinical and emerging clinical studies demonstrate that phlorotannins, fucoidans, fucoxanthin, lutein, zeaxanthin, ulvan, and astaxanthin exert antioxidant, anti-inflammatory, cholinergic-modulating and neuroprotective effects. Supplementation with seaweed-derived bioactive compounds has been shown to exert molecular and cellular effects that lead to reduced amyloid burden, preservation of synaptic integrity, and enhanced cognitive performance. Collectively, seaweed-derived compounds represent promising candidates for multi-target therapeutic strategies in cognitive decline prevention in the context of AD and healthy brain ageing.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SeaweedAlzheimer DiseaseNeuroprotective AgentsHumansAnimalsAntioxidantsAnti-Inflammatory AgentsOxidative Stress

Stichwörter der Autor:innen

Alzheimer’s diseasecognitive declinehealthy ageingneuroinflammationneuroprotectionoxidative stressseaweeds

Substanzen

Neuroprotective AgentsAntioxidantsAnti-Inflammatory Agents

Autor:innen und Institutionen

  • School of Behavioural and Health Sciences, Faculty of Health Sciences, Australian Catholic University, Banyo, QLD 4014, Australia.
  • Healthy Brain and Mind Research Centre, Australian Catholic University, Fitzroy, VIC 3065, Australia.
  • Centre for Genomics and Personalised Health, School of Biomedical Sciences, Queensland University of Technology, 60 Musk Ave, Kelvin Grove, QLD 4059, Australia.
  • Venus Shell Systems Pty Ltd., Huskisson, NSW 2540, Australia.
  • School of Medical, Indigenous and Health Science, University of Wollongong, Wollongong, NSW 2522, Australia.
  • Molecular Horizons, University of Wollongong, Wollongong, NSW 2522, Australia.

ORCID-Profile: Michael H Cole, Lyn R Griffiths, Heidi G Sutherland, Pia Winberg, Barbara J Meyer, Francesca Fernandez

Zitieren

APA

Ward, K., Cole, M. H., Griffiths, L. R., Sutherland, H. G., Winberg, P., Meyer, B. J., & Fernandez, F. (2025). Therapeutic Potentials of the Seaweed-Derived Compounds for Alzheimer’s Disease. Molecules, 30(22), 4456. https://doi.org/10.3390/molecules30224456

Vancouver

Ward K, Cole MH, Griffiths LR, Sutherland HG, Winberg P, Meyer BJ, et al. Therapeutic Potentials of the Seaweed-Derived Compounds for Alzheimer’s Disease. Molecules. 2025;30(22):4456. doi:10.3390/molecules30224456

BibTeX
@article{Ward2025,
  author = {Ward, Keanie and Cole, Michael H and Griffiths, Lyn R and Sutherland, Heidi G and Winberg, Pia and Meyer, Barbara J and Fernandez, Francesca},
  title = {Therapeutic Potentials of the Seaweed-Derived Compounds for Alzheimer’s Disease},
  journal = {Molecules},
  year = {2025},
  volume = {30},
  number = {22},
  pages = {4456},
  doi = {10.3390/molecules30224456}
}
Kostenlos starten →